Pembrolizumab is now approved

Pembrolizumab is now approved for first line treatment - Hallwang Clinic - Private Oncology Clinic on Facebook

Pembrolizumab is now also approved for first line treatment of metastatic or unresectable recurrent head and neck squamous cell carcinoma.
https://www.ascopost.com/News/60129

 

 

FDA Approves Pembrolizumab for the First-Line Treatment of Head and Neck Squamous Cell Carcinoma

Leave a Reply

Your email address will not be published. Required fields are marked *